Senhwa Biosciences, Inc., a clinical stage drug development company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer.
Currently 2 main compounds CX-5461 and CX-4945 are both first- in- class small molecule drugs and ongoing phase I/II clinical trials in Australia, Canada, United States, Korea and Taiwan.
Senhwa’s CX-5461 is a G-quadruplexes (G4) stabilizer, causing DNA damage of tumor cells through a synthetic lethality (SL) approach in patients with BRCA1/2 mutations or HR deficiency (HRD). Senhwa's CX-4945 is a selective CK2 inhibitor and it has been shown to inhibit the phosphorylation of the DNA repair protein XRCC1 and subsequently enhance the activity of DNA damaging chemotherapy agents.
Senhwa has a strong Management Team with proven track records in developing new drugs and targeted agents. Headquartered in Taiwan, but with a vital operational base in San Diego, California, the Senhwa Team is well positioned to oversee the development of their compounds by collaborating with a diverse range of global investigators and service providers.
Company Details
- Employees
- 36
- Founded
- -
- Address
- 10509 Vista Sorrento Parkway, Suite 201,taiwan, Province Of China
- Phone
- 8585526808
- Industry
- Biotechnology
- Website
- senhwabio.com
- Keywords
- Targeted Cancer Therapy, First In Class, DNA Damage Response, Synthetic Lethality, Orphan Drug, Multiple Indications, Rescue Medication, SU2C-CBCF Dream Team Drug, Precision Medicine.
- HQ
- San Diego, California
Senhwa Biosciences, Inc. Questions
Senhwa Biosciences, Inc.'s helpline number is 8585526808
Senhwa Biosciences, Inc.'s website is senhwabio.com
Senhwa Biosciences, Inc.'s LinkedIn profile is https://tw.linkedin.com/company/senhwa-biosciences
Senhwa Biosciences, Inc. has
36 employees.
View email and phone details for 36
employees at Senhwa Biosciences, Inc..
Senhwa Biosciences, Inc.'s industry is
Biotechnology
Senhwa Biosciences, Inc.'s top competitors are
Tyra Biosciences,
Belite Bio,
Caliway Biopharmaceuticals,
Ventyx Biosciences,
Oneness Biotech Co Ltd,
Pharmaessentia Corp.,
Cidara Therapeutics,
Anhorn Medicines,
Camino Pharma, Llc,
Aptose Biosciences, Inc..
Senhwa Biosciences, Inc.'s categories are Biotechnology
Senhwa Biosciences, Inc.'s founding year is 2012
